

SpringWorks Therapeutics Inc
(NASDAQ:SWTX)
SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing, and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing prevalent, genetically defined cancers. OGSIVEO, the first commercial product, is a novel, oral, selective gamma-secretase inhibitor. GOMEKLI, the second commercial product, is an oral, small molecule mitogen-activated protein kinase, or MEK, inhibitor.
top performing SWTX trades

Chris Jacobs
House (R-NY)
67.00%

Josh Gottheimer
House (D-NJ)
24.70%

Gilbert Ray Cisneros
House (D-CA)
-14.00%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent SpringWorks Therapeutics trades made by congress members.
![]() Gilbert Ray CisnerosHouse (D-CA) | $1K - $15K | stock | Purchase | Feb 11, 2025 | Jan 29, 2025 | House |
![]() Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Purchase | Aug 15, 2024 | Jul 19, 2024 | House |
![]() Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Jul 09, 2024 | Jun 18, 2024 | House |
![]() Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Purchase | Jun 08, 2024 | May 09, 2024 | House |
![]() Chris JacobsHouse (R-NY) | $1K - $15K | stock | Purchase | Jan 20, 2023 | Dec 12, 2022 | House |